Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myeloma

Added 119 days ago (27.01.2022)
Authors: Sophia Adamia; Shruti Bhatt; Kenneth Wen; Zuzana Chyra; Geoffrey G. Fell; Yu-Tzu Tai; Marisa S. Pioso; Ivane Abiatari; Anthony Letai; David M. Dorfman; Teru Hideshima; Kenneth C. Anderson
Journal: Leukemia
Read article